Tag: Obesity
Cardioprotective Effects of Semaglutide Independent of Adiposity
Greater waist circumference reduction at week 20 linked to lower subsequent MACE risk for those receiving semaglutide
Most U.S. Adults Unaware of Cardiovascular-Kidney-Metabolic Syndrome
Many lack awareness of CKM syndrome despite the fact that nearly nine in 10 have a risk factor for it
Incidence Rates Increased From 2003 to 2017 for Six Cancer Types in 42 Countries
Apart from colorectal cancer, increases in incidence were seen in both younger and older adults
New Definition of Obesity Led to Increased Prevalence of Obesity
Prevalence increased to 68.6 percent with new criteria, which include anthropometric measures such as waist circumference, waist-to-hip ratio, waist-to-height ratio
Stronger Grip Strength Protects Against Obesity-Related Outcomes
Authors say findings underscore the importance of improving muscle mass and strength in at-risk people
Weight-Loss Treatment Tied to Lower Risk for Obesity-Related Cancers
Findings seen for both medication and surgical procedures in people with obesity and type 2 diabetes
Metabolic Surgery Has Greater Long-Term Benefits Than GLP-1 Receptor Agonists
Findings seen for long-term outcomes among adult patients with diabetes and obesity
Patients With Extreme Obesity Face Limitations to Accessing Specialty Care
41 percent of practices declined to schedule appointment for hypothetical patient weighing 465 lb; 52 percent lacked basic standards of care
Oral Semaglutide Effective for Weight Loss in Overweight or Obesity
Estimated mean change in body weight from baseline to week 64 was −13.6 and −2.2 percent with oral semaglutide and placebo, respectively
Oral Orforglipron Yields Greater Weight Reductions Than Placebo
Significant mean change in body weight from baseline to week 72 seen with various dosages of orforglipron compared with placebo among adults with obesity












